Brief: ContraFect Corporation Announces Private Placement Of Common Stock And Warrants To Pfizer
May 26 (Reuters) - ContraFect Corp CFRX.O :
* CONTRAFECT CORPORATION ANNOUNCES PRIVATE PLACEMENT OF
COMMON
STOCK AND WARRANTS TO PFIZER INC.
* CONTRAFECT - PFIZER AGREED TO PURCHASE 674,156 SHARES OF
CO'S
STOCK & WARRANT TO PURCHASE 505,617 SHARES OF CO'S STOCK, FOR
ABOUT $3.0 MILLION
* CONTRAFECT - TO USE NET PROCEEDS TO CONTINUE FUNDING PHASE
3
DISRUPT TRIAL OF EXEBACASE IN STAPH AUREUS BACTEREMIA, WITH
RIGHT-SIDED ENDOCARDITIS
Source text for Eikon: ID:nGNXGymp6
Further company coverage: CFRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CONTRAFECT
See all newsBrief: Contrafect Corp - On Nov 7, Co Received Delisting Notification From Nasdaq Hearings Advisor Stating That Panel Determined To Delist Co's Common Stock
Brief: ContraFect Says Selling Securityholder May Offer And Selling Up To 7 Mln Shares In Aggregate Of Common Stock
Brief: Contrafect Announces FDA Clearance Of CF-370 IND Application To Proceed With Phase 1 Clinical Study
Brief: Contrafect Corp Says On Sept 21, Notified By Nasdaq, That Co Not In Compliance With The Minimum Bid Price Requirement
Brief: Contrafect Announces Submission Of Ind Application To The FDA For Its Development Candidate Cf-370